Create your page here
Lupin Bolsters US Brands Portfolio with Methergine® Oral Tablets
Edit Stockhouse 28 Apr 2016
"I commend Lupin for spotlighting this public health issue and making an investment in treatment, education and awareness of PPH." ... Lupin is the 5th largest generics player in the US (5.6% market share by prescriptions, IMS Health) and amongst the fastest growing top 10 generic pharmaceutical players in Japan (ranked 9th) and South Africa (ranked 4th - IMS Health)....
Teligent, Inc. Announces First Quarter 2016 Results (Teligent Inc)
Edit Public Technologies 28 Apr 2016
(Source. Teligent Inc). BUENA, N.J., April 28, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ ... Mr ... Based on IMS Health data as of February, 2016, the current total addressable market of these pipeline ANDAs is estimated at $1.5 billion, excluding our three remaining partnered submissions ... We also have four applications pending with Health Canada for our Canadian injectable business.' ... International participants should call 1-412-902-4260 ... call....
2016 first quarter results press release (Laboratorios Farmacéuticos ROVI SA)
Edit Public Technologies 27 Apr 2016
For 2016, ROVI expects a mid-to-high single digit growth rate for the operating revenue, despite (i) a 0.6% slight rise in the Spanish pharmaceutical market according to Farmaindustria1, and (ii) stable annual growth between 1.3% and 1.6% in the Spanish pharmaceutical market for the period 2016-2019 forecast by IMS Health2 ... According to IMS Health, Spanish innovative product market increased by 2.6% in the first quarter of 2016....
Ocular TherapeutixTM Completes End-of-Phase 2 Review with FDA for OTX-TP (Sustained Release Travoprost) for Glaucoma and Ocular Hypertension (Ocular Therapeutix Inc)
Edit Public Technologies 27 Apr 2016
(Source. Ocular Therapeutix Inc). First Phase 3 trial expected to commence in the third quarter of 2016. Trial design to evaluate OTX-TP using placebo as comparator; no timolol validation arm required. BEDFORD, Mass.--(BUSINESS WIRE)--Apr ... In the U.S ... According to IMS Health data, there were 34 million prescriptions and sales of over $2.7 billion of drugs administered by eye drops for the treatment of glaucoma in the U.S. in 2015 ... (NASDAQ....
Glenmark Gets USFDA Tentative Nod For Oral Contraceptives
Edit NDTV 26 Apr 2016
According to IMS Health sales data for the 12 months to February 2016, Lo Loestrin Fe achieved annual sales of around $432.2 million, Glenmark said. ....
Mankind’s next force
Edit Yahoo Daily News 25 Apr 2016
For the month ending March 2015, the company ranked fourth by value and fifth by revenue as per IMS Health Market reflection report ... According to IMS Health, top 30 pharmaceutical companies in India are looking at nutraceuticals as an avenue for future growth. Not only is this is a reflection of an increased awareness of health and well being among ......
Oriola-KD Corporation's Interim Report for 1 January-31 March 2016
Edit Stockhouse 22 Apr 2016
Oriola-KD Corporation Stock Exchange Release 22 April 2016 at 8.30 a.m. Oriola-KD Corporation's Interim Report for 1 January-31 March 2016 ... EUR million 1-3 1-3 1) % 1-12. Continued operations . Invoicing 834.4 793.3 5.2 3,262.2 ... Consumer. The Consumer segment focuses on the needs of the consumers' for health and wellbeing related products and services ... IMS Health) ... IMS Health) in January-March 2016 ... IMS Express) ... ....
Pills That Deliver Injection-Only Drugs
Edit Bloomberg 21 Apr 2016
Innovator. Mir Imran. Age. 59. Founder of Rani Therapeutics, based in San Jose. Form and function. Genetically engineered drugs known as biologics typically have to be injected rather than swallowed because their complex proteins break down in the stomach. Rani Therapeutics is developing a pill that will protect those proteins. Background ... Funding ... Spending on biologics topped $230 billion last year, estimates researcher IMS Health ... 1 ... 2 ... ....
IMS Health to Announce First-Quarter 2016 Results on May 4, 2016 (IMS Health Holdings Inc)
Edit Public Technologies 20 Apr 2016
IMS Health Holdings Inc). DANBURY, Conn.--(BUSINESS WIRE)-- IMS Health Holdings, Inc. ('IMS Health') (NYSE.IMS) will issue its first-quarter 2016 financial results before the market opens on Wednesday, May 4, 2016. The earnings release and accompanying financial information will be posted on the IMS Health Investor Relations website at http.//ir.imshealth.com ... About IMS Health ... IMS Health. IMS Health Holdings Inc....
20 Apr 2016 - IMS Health to Announce First-Quarter 2016 Results On May 4, 2016 (IMS Health Canada Ltd)
Edit Public Technologies 20 Apr 2016
IMS Health Canada Ltd). DANBURY, Conn.--(BUSINESS WIRE)-- IMS Health Holdings, Inc. ('IMS Health') (NYSE.IMS) will issue its first-quarter 2016 financial results before the market opens on Wednesday, May 4, 2016. The earnings release and accompanying financial information will be posted on the IMS Health Investor Relations website at http.//ir.imshealth.com ... About IMS Health ... IMS Health. IMS Health Canada Ltd....
IMS Health to Announce First-Quarter 2016 Results on May 4, 2016
Edit Business Wire 20 Apr 2016
DANBURY, Conn.--(BUSINESS WIRE)--IMS Health Holdings, Inc. (“IMS Health”) (NYSE.IMS) will issue its first-quarter 2016 financial results before the market opens on Wednesday, May 4, 2016. The earnings release and accompanying financial information will be posted on the IMS Health Investor Relations website at http.//ir.imshealth.com....
20 Apr 2016 - Real-World Evidence Solutions Workshop at World Orphan Drug Congress (IMS Health Canada Ltd)
Edit Public Technologies 19 Apr 2016- 1
- 2
- 3
- 4
- 5
- Next page »
